FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING Read more about FENNEC ANNOUNCES RESULTS OF ANNUAL MEETING
FENNEC TO PRESENT AT CANTOR FITZGERALD’S 2ND ANNUAL HEALTHCARE CONFERENCE IN NEW YORK ON JULY 13, 2016 Read more about FENNEC TO PRESENT AT CANTOR FITZGERALD’S 2ND ANNUAL HEALTHCARE CONFERENCE IN NEW YORK ON JULY 13, 2016
FENNEC ANNOUNCES APPOINTMENT OF MARCO BRUGHERA TO THE BOARD OF DIRECTORS Read more about FENNEC ANNOUNCES APPOINTMENT OF MARCO BRUGHERA TO THE BOARD OF DIRECTORS
FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES SECOND QUARTER 2016 RESULTS Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES SECOND QUARTER 2016 RESULTS
FENNEC TO PRESENT AT RODMAN & RENSHAW 18TH ANNUAL GLOBAL INVESTMENT CONFERENCE IN NEW YORK ON SEPTEMBER 13, 2016 Read more about FENNEC TO PRESENT AT RODMAN & RENSHAW 18TH ANNUAL GLOBAL INVESTMENT CONFERENCE IN NEW YORK ON SEPTEMBER 13, 2016
FENNEC ANNOUNCES UPDATE OF SIOPEL 6 STUDY ON SODIUM THIOSULFATE (STS) PRESENTED AT THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP) 2016 MEETING Read more about FENNEC ANNOUNCES UPDATE OF SIOPEL 6 STUDY ON SODIUM THIOSULFATE (STS) PRESENTED AT THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP) 2016 MEETING
FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES THIRD QUARTER 2016 RESULTS Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES THIRD QUARTER 2016 RESULTS
FENNEC ANNOUNCES THE LANCET ONCOLOGY PUBLICATION OF CHILDREN’S ONCOLOGY GROUP STUDY OF SODIUM THIOSULFATE Read more about FENNEC ANNOUNCES THE LANCET ONCOLOGY PUBLICATION OF CHILDREN’S ONCOLOGY GROUP STUDY OF SODIUM THIOSULFATE
FENNEC TO PRESENT AT 19TH ANNUAL BIO CEO & INVESTOR CONFERENCE Read more about FENNEC TO PRESENT AT 19TH ANNUAL BIO CEO & INVESTOR CONFERENCE
FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES FISCAL YEAR ENDED DECEMBER 31, 2016 FINANCIAL RESULTS Read more about FENNEC PROVIDES CORPORATE UPDATE AND ANNOUNCES FISCAL YEAR ENDED DECEMBER 31, 2016 FINANCIAL RESULTS
